Ratos: Johan von Heijne new CEO of Biolin Scientific

11 januari 2013 This information is disclosed in accordance with the Securities Markets Act, the Financial Instruments Trading Act or demands made in the exchange rules. Johan von Heijne has been appointed as the new CEO of Ratos's subsidiary Biolin Scientific with effect from 1 February 2013. Johan von Heijne has long and sound experience within the biotechnology sector. Johan von Heijne, born 1961, will join Biolin Scientific from GE Healthcare Life Sciences where he has been General Manager of the Research Products business area since 2008. In this role Johan was responsible for a product area with annual sales of USD 500m worldwide and manager for more than 100 employees in several countries. He has previously held leading positions within Biacore and Radi Medical, among others. The Chairman of Biolin's Board, Peter Ehrenheim, comments: "Johan von Heijne has broad experience within Life Sciences Tools, and a documented ability to get things done, most recently at General Electric. His broad experience and strategic talents make him a highly suitable CEO for Biolin Scientific. We on the Board are convinced that Johan, together with other members of the management team, can develop Biolin Scientific into a strong and expansive company." Johan von Heijne will take up his position on 1 February 2013 and succeed Jan Wahlström. Biolin Scientific develops, manufactures and markets analytical instruments for research, development, quality control and dental diagnostics. The company is specialised in surface measurement with applications within Life Sciences but also within material science and nanotechnology. The company also holds a very strong position within cell analysis for pharmaceutical development. Customers are found worldwide and mainly comprise researchers in pharmaceutical companies and universities. For further information, please contact: Henrik Joelsson, Investment Director, Ratos, +46 8 700 17 00 Peter Ehrenheim, Chairman of Biolin Scientific, +46 706 67 57 11 Johan von Heijne, incoming CEO Biolin Scientific, +46 705 95 15 10 Emma Rheborg, Head of Corporate Communications and IR, Ratos, +46 8 700 17 00 Financial calendar from Ratos: Year-end report 2012 15 February 2013 Annual General Meeting 2013 17 April 2013 Interim Report January - March 2013 8 May 2013 Interim Report January - June 2013 15 August 2013 Interim Report January - September 2013        8 November 2013 Ratos is a private equity conglomerate. The company's mission is to maximise shareholder value over time through the professional, active and responsible exercise of its ownership role in primarily medium to large unlisted Nordic companies. Ratos's holdings include AH Industries, Arcus-Gruppen, Biolin Scientific, Bisnode, DIAB, Euromaint, Finnkino, GS-Hydro, Hafa Bathroom Group, HL Display, Inwido, Jøtul, KVD Kvarndammen, Mobile Climate Control, SB Seating and Stofa. Ratos is listed on Nasdaq OMX Stockholm and market capitalisation amounts to approximately SEK 20 billion. Press release: http://hugin.info/1180/R/1669668/542500.pdf This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that: (i) the releases contained herein are protected by copyright and other applicable laws; and (ii) they are solely responsible for the content, accuracy and originality of the information contained therein. Source: Ratos via Thomson Reuters ONE [HUG#1669668]